US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree International High Dividend Fund

58.39

+0.37470.65%

Post-market: 58.39-0.00290.00%19:30 EDT

Volume:15.32K

Turnover:895.07K

Market Cap:662.70M

PE:- -

High:58.64

Open:58.62

Low:58.31

Close:58.01

52wk High:59.18

52wk Low:46.43

Shares:11.35M

Float Shares:11.35M

Volume Ratio:0.57

T/O Rate:0.13%

Dividend:2.18

Dividend Rate:3.74%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

Press Release: Eutelsat Communications: Third Quarter and Nine-Month 2025-26 Revenues

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/DTH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DTH\",,,,,undefined,":{"symbol":"DTH","market":"US","secType":"STK","nameCN":"WisdomTree International High Dividend Fund","latestPrice":58.3879,"timestamp":1789156800000,"preClose":58.0132,"halted":0,"volume":15315,"hourTrading":{"tag":"盘后","latestPrice":58.385,"preClose":58.3879,"latestTime":"19:30 EDT","volume":13,"amount":759.0473,"timestamp":1789169407542,"change":-0.0029,"changeRate":-0.00005,"amplitude":0},"delay":0,"changeRate":0.006458874876752261,"floatShares":11350000,"shares":11350000,"eps":0,"marketStatus":"Market Closed","change":0.3747,"latestTime":"09-11 16:00:00 EDT","open":58.62,"high":58.64,"low":58.31,"amount":895073.3058750001,"amplitude":0.005688,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":58.0132,"sharesOutstanding":11650000,"nav":58.122395,"aum":660929285.03,"dividendRate":0.037359,"bidAskSpread":0.001333,"postHourTrading":{"tag":"盘后","latestPrice":58.385,"preClose":58.3879,"latestTime":"19:30 EDT","volume":13,"amount":759.0473,"timestamp":1789169407542,"change":-0.0029,"changeRate":-0.00005,"amplitude":0},"volumeRatio":0.5737846211609012,"impliedVol":0.0982,"impliedVolPercentile":0.6614},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DTH\",,,,,undefined,":{"symbol":"DTH","floatShares":11350000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5737846211609012,"shares":11350000,"dividePrice":2.1813,"high":58.64,"amplitude":0.005688,"preClose":58.0132,"low":58.31,"week52Low":46.43,"pbRate":"--","week52High":59.1775,"institutionHeld":0,"latestPrice":58.3879,"eps":0,"divideRate":0.037359,"volume":15315,"delay":0,"ttmEps":0,"open":58.62,"prevYearClose":51.6046,"prevWeekClose":58.8765,"prevMonthClose":58.51,"prevQuarterClose":54.11,"fiveDayClose":58.945,"twentyDayClose":58.2013,"sixtyDayClose":56.6702},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DTH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"DTH","amount":1.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"WisdomTree DEFA Equity Income","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-29","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-29"},{"date":"2026-03-26","symbol":"DTH","amount":0.165,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"WisdomTree DEFA Equity Income","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-30","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-30"},{"date":"2025-12-26","symbol":"DTH","amount":0.42802,"announcedDate":"2025-12-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-26","defaultRemindTime":1766759400000,"name":"WisdomTree DEFA Equity Income","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-30","payableDate":"2025-12-26","currency":"USD","dateTimestamp":1766725200000,"payDate":"2025-12-30"},{"date":"2025-09-25","symbol":"DTH","amount":0.37,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"WisdomTree DEFA Equity Income","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-29"},{"date":"2025-06-25","symbol":"DTH","amount":0.95,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"WisdomTree DEFA Equity Income","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DTH\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.24,"currency":"USD"},{"executeDate":"2016-12-23","recordDate":"2016-12-28","paymentDate":"2016-12-30","value":0.32996,"currency":"USD"},{"executeDate":"2017-03-27","recordDate":"2017-03-29","paymentDate":"2017-03-31","value":0.27,"currency":"USD"},{"executeDate":"2017-06-26","recordDate":"2017-06-28","paymentDate":"2017-06-30","value":0.715,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.335,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DTH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640958683","title":"Greenwich LifeSciences Provides Update Regarding Form 10-K Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640958683","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640958683?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:00","pubTimestamp":1780308000,"startTime":"0","endTime":"0","summary":"STAFFORD, Texas, June  01, 2026  (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the \"Company\"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FL","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304129/0/en/Greenwich-LifeSciences-Provides-Update-Regarding-Form-10-K-Filing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI","BK4139","DTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637631319","title":"BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637631319","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637631319?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:30","pubTimestamp":1779449400,"startTime":"0","endTime":"0","summary":"Final Phase 2 Bria-IMT median overall survival (OS) is 16.6 months (with Phase 3 formulation) Positive Quality of Life (QOL) data from the ongoing Phase 3 study in heavily pre-treated metastatic breas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3300068/0/en/BriaCell-Presentations-Highlight-Positive-Clinical-Data-for-Bria-IMT-at-ASCO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","PFS","MBC","BK4080","BK4211","CPS","BK4195","ADC","DTH","BK4231","BK4086","CPI","BK4124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634245190","title":"Press Release: Eutelsat Communications: Third Quarter and Nine-Month 2025-26 Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2634245190","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634245190?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:55","pubTimestamp":1778601300,"startTime":"0","endTime":"0","summary":"--  Third Quarter Operating Verticals revenues of EUR283.7m, up 0.9%1. --  Sustained double digit growth 1 in Connectivity, driven by LEO--enabled. Eutelsat Communications  reports revenues for the Third Quarter and Nine Months ended 31 March 2026.In EUR millions            Q3 2024-25  Q3 2025-26            Change. Total revenues for the Third Quarter of Financial Year 2025-26 stood at EUR293.0 million, down 2.3% on a reported basis, and up by 3.1% like-for-like.Revenues of the four Operating Verticals  stood at EUR283.7 million. They were up 0.9% on a like-for-like basis . Quarter--on--quarter, revenues of the four Operating Verticals were down 1.9% like-for-like .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631368778","title":"Greenwich LifeSciences Provides Update Regarding Form 10-K Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631368778","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631368778?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:00","pubTimestamp":1777543200,"startTime":"0","endTime":"0","summary":"STAFFORD, Texas, April  30, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the \"Company\"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FL","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/30/3284599/0/en/Greenwich-LifeSciences-Provides-Update-Regarding-Form-10-K-Filing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DTH","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620286122","title":"Immutep Reports Progress from Phase I Study of LAG-3 Agonist for  Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2620286122","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620286122?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:00","pubTimestamp":1773921600,"startTime":"0","endTime":"0","summary":"Immutep has completed the single ascending dose (SAD) portion of its IMP761 studyIMP761 was well tolerated across all dose levels IMP761 data and Phase I results will be presented at the EULAR confere","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3258946/0/en/Immutep-Reports-Progress-from-Phase-I-Study-of-LAG-3-Agonist-for-Autoimmune-Diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","BK4097","DTH","BK4139","IMMP","PRGS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":45,"code":"91000000","status":"200"}]}}